Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Feb 22, 2017 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor, Wal-Mart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor and Wal-Mart.

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Feb 2, 2017 at 4:43 PM EST

Why Amgen Earnings Are So Incredible

Amgen Inc. (NASDAQ: AMGN) reported its fourth-quarter financial results after the markets closed on Thursday. This biotech giant posted $2.89…

Chris Lange | Feb 1, 2017 at 3:11 PM EST

Top 6 Earnings To Watch For On Thursday

Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems…

Jon C. Ogg | Feb 1, 2017 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Apple, Corning, Mobileye, Under Armour, Electronic Arts and Many More

The top analyst upgrades, downgrades and initiations seen on Wednesday include Amgen, Apple, Corning, Mobileye, Under Armour and Electronic Arts.

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

Chris Lange | Jan 12, 2017 at 9:35 AM EST

Biotech Short Sellers Run for Cover

As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…

Chris Lange | Jan 6, 2017 at 11:55 AM EST

Friday’s 6 Biopharma Movers That Can’t Be Ignored

2017 could be different for the health care sector. It is very possible that this new administration could lead to…

Chris Lange | Dec 28, 2016 at 10:10 AM EST

Biotech Short Interest Sinks

The December 15 short interest data have been compared with the previous report, and short interest was down in most…

Jon C. Ogg | Dec 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More

Tthe top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, American Express, American Water Works, Celgene and…

Jon C. Ogg | Dec 13, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld…

Chris Lange | Dec 12, 2016 at 9:10 AM EST

Biotech Short Interest Remains Mixed

The November 30 short interest data have been compared with the previous report, and short interest was mixed in the…

Chris Lange | Nov 28, 2016 at 7:35 AM EST

Short Sellers Grow More Aggressive on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest increased in most of…

Lee Jackson | Nov 11, 2016 at 9:35 AM EST

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there…

1 … 19 20 21 22 23 … 47

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor, Wal-Mart and More

Major Biotechs Scare Off Loads of Short Sellers

Why Amgen Earnings Are So Incredible

Top 6 Earnings To Watch For On Thursday

Top Analyst Upgrades and Downgrades: Amgen, Apple, Corning, Mobileye, Under Armour, Electronic Arts and Many More

Short Sellers Back Off Major Biotechs

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Biotech Short Sellers Run for Cover

Friday’s 6 Biopharma Movers That Can’t Be Ignored

Biotech Short Interest Sinks

Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

Biotech Short Interest Remains Mixed

Short Sellers Grow More Aggressive on Major Biotechs

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor, Wal-Mart and More

Major Biotechs Scare Off Loads of Short Sellers

Why Amgen Earnings Are So Incredible

Top 6 Earnings To Watch For On Thursday

Top Analyst Upgrades and Downgrades: Amgen, Apple, Corning, Mobileye, Under Armour, Electronic Arts and Many More

Short Sellers Back Off Major Biotechs

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Biotech Short Sellers Run for Cover

Friday’s 6 Biopharma Movers That Can’t Be Ignored

Biotech Short Interest Sinks

Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

Biotech Short Interest Remains Mixed

Short Sellers Grow More Aggressive on Major Biotechs

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%